Chronic prostatitis
Conditions
Sponsors
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) The diagnostic criteria of type II and Type IIIA chronic prostatitis were met; (2) It is in accordance with the diagnostic criteria of dampness heat stasis and kidney deficiency syndrome; (3) The age ranged from 18 to 50 years old; (4) Patients with a course of disease >= 3 months and who had been treated before treatment could be included in the study only after stopping using all relevant Chinese and Western medicines for chronic prostatitis for at least 2 weeks; (5) Those who voluntarily participate in this clinical trial, and have informed consent and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with benign prostatic hyperplasia, prostate tumor, neurogenic bladder dysfunction, urethral malformation or stenosis, severe neurosis; (2) Patients with urinary tract infection and urethritis; (3) Other diseases such as ureter, bladder stones, inguinal hernia, pubitis, varicocele, epididymitis, rectocolonitis, lumbosacral myofascitis, etc. should be excluded if local pain is the main manifestation; (4) Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; (5) Psychiatric patients, diabetic patients, urinary calculi patients; (6) The subjects are participating in clinical trials of other drugs at the same time or using drugs with similar therapeutic effects as the trial drugs; (7) Allergic constitution (including drug allergy, food allergy and other allergic constitution); (8) The subjects were not willing to participate in the trial or could not cooperate with the treatment due to alcoholism and / or psychoactive substances, drug abusers and addicts, and avoiding spicy diet; (9) Those considered unsuitable for clinical trials by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentration of ciprofloxacin and relinquin markers;NIH-CPSI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bacterial culture of prostatic fluid; | — |
Countries
China
Contacts
Public ContactHuang Yu-Hong
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed